Dr. Daniel E. Freedberg's educational path is marked by his commencement at Harvard Medical School, leading to a residency and fellowship at New York-Presbyterian Hospital/Columbia University Medical Center. His academic journey is further distinguished by a Master's degree in biostatistics, which he obtained from Columbia's Mailman School of Public Health, signifying his deep commitment to integrating statistical rigor with medical research.
At the core of Dr. Freedberg’s research is a pioneering investigation into the gastrointestinal microbiome's role in health and disease, particularly during critical periods of hospitalization. His work, recognized and funded by renowned institutions, investigates the effects of acid suppression medications and their interactions with the gut microbiome, aiming to mitigate the risks of hospital-acquired infections. Dr. Freedberg's expertise and scholarly endeavors make him a venerated figure in the field of gastroenterology, where he continues to contribute significantly to our understanding of microbial dynamics in clinical settings.
He works in the gastroenterology department.
Dr. Daniel works at - NewYork-Presbyterian / Columbia University Irving Medical Center.
Dr. Daniel specializes in diseases and treatments such as digestive system disorder, gastrointestinal disease and general gastroenterology, gastroesophageal reflux disease.